The Executive Board, having reviewed the report presented by the Director-General, recommends the adoption of a resolution to the Seventy-seventh World Health Assembly regarding the ethical access, oversight, and increased availability of transplantation of human cells, tissues, and organs. This draft decision is proposed jointly by Argentina, Brazil, China, the European Union and its 27 Member States, Peru, and Qatar (1^✔ ✔Trusted Source
Increasing availability, ethical access and oversight of transplantation of human cells, tissues and organs

Go to source

).

Preamble on Transplantation of Human Cells, Tissues, and Organs

1. Having considered the report by the Director-General.




2. Recalling Health Assembly resolutions on development of guiding principles for human organ transplants, on preventing the purchase and sale of human organs and on human organ transplantation, on human organ and tissue transplantation and on human organ and tissue transplantation.




3. Noting initiatives by WHO regions in advancing the implementation of current
   resolutions on transplantation, including decisions taken by the WHO Regional Committee for the Americas and the WHO Regional Committee for Africa.




4. Noting the report by the Secretariat on principles on the donation and management
   of blood, blood components and other medical products of human origin, that promotes respect for human dignity, availability and safety, and good governance.




5. Welcoming the United Nations General Assembly resolution 77/236 on
   strengthening and promoting effective measures and international cooperation on organ donation and transplantation to prevent and combat trafficking in persons for the purpose of organ removal and trafficking in human organs.




6. Noting the Madrid resolution on organ donation and transplantation (2011),an outcome of the Third WHO Global Consultation on Organ Donation and Transplantation (2010) that provides recommendations for countries to progress towards meeting the transplant needs of patients.




7. Aware that transplantation is currently the preferred, if not the only, therapeutic
   alternative for patients with end-stage organ failure and that many other diseases benefit from the clinical application of human cells and tissues, and that such treatments depend on the altruistic donation of cells, tissues and organs.




8. Conscious that, despite the priority given by many Member States to prevention
   strategies, the burden of noncommunicable diseases treatable through transplantation continues to grow, as does the commensurate need for transplantation of human cells, tissues and organs.




9. Mindful that facilitating access to transplantation of human cells, tissues and organs
   can reduce the premature mortality associated with noncommunicable and other diseases,
   improve the quality of life of thousands of patients throughout the world, and help communities to diminish the high costs of alternative treatment modalities.





10. Noting that expanded access to transplant therapies might contribute to the
    achievement of the United Nations Sustainable Development Goals, in particular, targets 3.4
    (reduction of premature mortality from noncommunicable diseases) and 3.8 (access to universal health care).




11. Aware that, despite the progress made over the past two decades, transplantation is
    not fully developed in all Member States, making access to these therapies neither universal nor equitable, a problem that impacts countries regardless of their level of development.




12. Noting with concern that the COVID-19 pandemic had a profound, negative effect on donation and transplantation activities, revealing the need to consider including transplant therapies in approaches designed to strengthen the resilience of health care systems.




13. Convinced that insufficient access to transplantation therapies is one of the root
    causes of trafficking in persons for the purpose of organ removal and trafficking in human organs, practices that undermine human rights and pose serious risks to public health.




14. Alarmed that armed conflicts, natural disasters and humanitarian emergencies are
    fuelling migration, particularly among disadvantaged populations and those in the most
    vulnerable situations, thereby increasing the risk of trafficking in persons for the purpose of organ removal and trafficking in human organs, and exacerbating inequities in access to therapies based on human cells, tissues and organs.
15. Noting with concern the lack of full implementation of the WHO Guiding Principles
    on Human Cell, Tissue and Organ Transplantation, particularly regarding transparent data
    reporting and health authority oversight of transplant practices.
16. Aware that technological innovations applicable to human cells, tissues, and organs
    are increasingly enabling therapies that, given the unique origin of these novel treatments, require specific regulations with a particular focus on ethical considerations.

Operational Paragraphs (OP) Urging Member States:

1. To implement or strengthen existing preventive strategies targeted at reducing the
   burden of noncommunicable and other diseases treatable with transplantation;





2. To integrate donation, transplantation and transplant follow-up activities into health
   care systems, so deceased donation is routinely considered as an option at the end of life
   and transplantation is incorporated in the continuum of care of patients with
   noncommunicable and other diseases or conditions that may benefit from this therapy, by
   pursuing policies that support universal health coverage and eliminate financial barriers to
   access quality, safe, effective, affordable and essential health services;





3. To protect living donors by requiring informed consent and appropriate medical and
   psychosocial evaluation, as well as by providing proper follow-up care;





4. To increase the availability of human cells, tissues and organs for transplantation with
   special attention to developing deceased donation to its maximum therapeutic potential,
   including donation after the neurological determination of death and, where appropriate,
   donation after the circulatory determination of death, and in line with the relevant
   WHO Guiding Principles on Human Cell, Tissue and Organ Transplantation;





5. To establish, where appropriate, official international cooperation for the exchange
   of human cells, tissues and organs or transplant services, based on the principles of
   reciprocity and solidarity, as a means to facilitate universal access to transplantation
   Therapies;





6. To develop and implement regulatory frameworks aligned with the WHO Guiding
   Principles on Human Cell, Tissue and Organ Transplantation, in particular by encouraging
   donation as an altruistic, voluntary and non-remunerated act and by promoting equitable
   access to transplantation therapies;





7. To designate authorities and improve capacities to provide governance and
   implementation of donation and transplantation activities in their jurisdictions;





8. To promote that donation and transplantation activities take place in centers
   specifically authorized, accredited or registered and establish control measures, such as
   periodic or risk-based inspections and the collection and timely reporting of data on every
   donation and transplant procedure, including transplants carried out on residents in other
   Jurisdictions;





9. To promote the safety and efficacy of transplantation by collecting data on the
   outcomes of recipients and living donors, conducting biovigilance and relevant
   surveillance, ensuring capacity to trace cells, tissues and organs from donor to recipient,
   and vice versa, and encouraging the use of global consistent coding systems for human
   cells, tissues and organs;





10. To consider including donation and transplantation in national and regional
    preparedness plans designed to increase the resilience of health care systems and to
    facilitate an effective response to transplant needs in the event of crisis;





11. To take measures to prevent and combat trafficking in persons for the purpose of
    organ removal and trafficking in human organs and to protect victims and survivors of these
    crimes by strengthening legislative frameworks, enforcing clinical protocols for the
    psychosocial evaluation of prospective living donors, engaging health care professionals,
    governments and other stakeholders in reporting suspected or confirmed cases of
    trafficking to law enforcement agencies, promoting international cooperation,
    and collecting data and conducting research on the trends in both crimes;





12. To promote research and innovation to maximize the use and optimize the outcomes
    of transplantation of human cells, tissues and organs, as well as enable development of
    alternative therapies to those based on the clinical use of human cells, tissues and organs;





13. To implement regulatory frameworks applicable to innovative therapies developed
    from substantially manipulated cells, tissues and organs that ensure the protection of donors
    and recipients, and that pursue equity in access to these novel therapies and sustainable
    health care systems;





14. To participate in consultations organized by WHO to develop a global strategy on
    donation and transplantation; and





15. To consider providing appropriate support to WHO in implementing this resolution.

Requests to the Director-General:

1. To provide Member States, upon request, with technical assistance for developing
   national legislation and regulations aligned with the WHO Guiding Principles on Human
   Cell, Tissue and Organ Transplantation, assessing transplantation needs, establishing or
   strengthening national authorities, improving capacities to increase the availability of cells,
   tissues and organs, and implementing ethical, effective and safe transplant programmes;





2. To assist Member States, upon request, to strengthen their regulatory capacity to
   effectively oversee donation and transplantation practices, including through monitoring
   and evaluating transplantation programme performance and donor and recipient outcomes;





3. To continue collecting, analyzing and making available to Member States global data
   on the legislation, regulations, practices, safety, quality, effectiveness, epidemiology and
   ethics of donation and transplantation of human cells, tissues and organs;





4. To revise the WHO Guiding Principles on Human Cell, Tissue and Organ Transplantation to incorporate additional principles that address new ethical challenges posed by scientific advancements in the field, in particular principles to safeguard the intrinsic value of novel products and treatments that are developed from human cells, tissues and organs;





5. To continue and strengthen cooperation with United Nations agencies, including the
   United Nations Office on Drugs and Crime, interagency mechanisms, Member State
   ministries and other relevant stakeholders to improve country, regional and global capacity
   to respond to identified cases of trafficking in persons for the purpose of organ removal
   and of trafficking in human organs;





6. To provide, in cooperation with key international professional associations and other
   relevant stakeholders, reference guidance to Member States on the diagnosis of death by
   neurological and by circulatory criteria;





7. To develop, in consultation with Member States, nongovernmental organizations and
   other relevant stakeholders in accordance with the Framework of Engagement with
   Non-State Actors and within existing resources, a global strategy on donation and
   transplantation, for consideration by the Seventy-ninth World Health Assembly, through
   the Executive Board at its 158th session, that supports Member States to integrate donation
   and transplantation into health care systems and promotes the implementation of the
   WHO Guiding Principles on Human Cell, Tissue and Organ Transplantation;





8. To further explore, as part of the global strategy referred to in OP2(7), and in accordance with the current framework for world health days, the feasibility and potential impact of establishing a World Donor Day to raise public awareness and enhance understanding on the need for altruistic donation of human cells, tissues and organs and propel global action by Member States to structure appropriate donation and transplantation systems, taking into consideration the existence of other relevant events either observed by WHO or established by other international entities;





9. To establish an expert committee in accordance with the Regulations for Expert
   Advisory Panels and Committees, to assist the Secretariat in developing the proposed
   global strategy on donation and transplantation and support its implementation;





10. To provide a consolidated report on progress in the implementation of this resolution
    in 2026 to the Seventy-ninth World Health Assembly, through the Executive Board at its
    158th session, as well as on progress in the implementation of resolution WHA63.22 on
    human organ and tissue transplantation.

Reference:

1. Increasing availability, ethical access and oversight of transplantation of human cells, tissues and organs – (https://apps.who.int/gb/ebwha/pdf_files/EB154/B154(7)-en.pdf)

Source-Medindia